Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sagent Pharmaceuticals has rolled out vecuronium bromide for injection in 10 and 20mg single-use vials.
Subscribe to our email newsletter
Vecuronium bromide for injection is indicated for the patients with myasthenia gravis or the myasthenic (Eaton-Lambert) syndrome (muscle weakness/fatigue).
The injection features Sagent’s PreventIV Measures packaging and labeling designed to aid in the reduction of medication errors.
Sagent CEO and chairman of the board Jeffrey Yordon said Vecuronium bromide is currently in short supply in the US and they are pleased to offer customers a source for this important niche product.